Literature DB >> 9067584

Hypermethylation of a 5' CpG island of p16 is a frequent event in non-Hodgkin's lymphoma.

B Martinez-Delgado1, J Fernandez-Piqueras, M J Garcia, E Arranz, J Gallego, C Rivas, M Robledo, J Benitez.   

Abstract

Hypermethylation of a 5' CpG island of p16 gene has been recently described as a possible way of inactivation of this tumor suppressor gene, alternative to deletions and mutations. We have investigated if hypermethylation of a 5' CpG island of p16 occurs in non-Hodgkin's lymphoma (NHL) and normal lymphoid tissue. A total of 82 NHLs were examined for p16 methylation by Southern blot and PCR analysis. Hypermethylation was detected in approximately 20% of B cell lymphomas of both low and high grade and in 15% of T cell NHL. The highest rate of p16 gene methylation in tumors was found among MALT (mucosa-associated lymphoid tissue) lymphomas in which the percentage of cases with p16 gene methylation reached 67%. However, normal lymphoid tissue was always unmethylated at p16 locus. These results indicate that p16 gene methylation is a frequent event in NHLs, mainly in MALT lymphomas, and suggest that it could be an important mechanism of inactivation of this gene.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9067584     DOI: 10.1038/sj.leu.2400579

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  14 in total

Review 1.  Epigenetic inactivation of tumor suppressor genes in hematologic malignancies.

Authors:  Tomohiro Kinoshita
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

2.  Overall survival in aggressive B-cell lymphomas is dependent on the accumulation of alterations in p53, p16, and p27.

Authors:  M Sánchez-Beato; A I Sáez; I C Navas; P Algara; M Sol Mateo; R Villuendas; F Camacho; A Sánchez-Aguilera; E Sánchez; M A Piris
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

3.  Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphoma.

Authors:  Thomas Clozel; ShaoNing Yang; Rebecca L Elstrom; Wayne Tam; Peter Martin; Matthias Kormaksson; Samprit Banerjee; Aparna Vasanthakumar; Biljana Culjkovic; David W Scott; Sarah Wyman; Micheal Leser; Rita Shaknovich; Amy Chadburn; Fabrizio Tabbo; Lucy A Godley; Randy D Gascoyne; Katherine L Borden; Giorgio Inghirami; John P Leonard; Ari Melnick; Leandro Cerchietti
Journal:  Cancer Discov       Date:  2013-08-16       Impact factor: 39.397

4.  Loss of p16/INK4A protein expression in non-Hodgkin's lymphomas is a frequent finding associated with tumor progression.

Authors:  R Villuendas; M Sánchez-Beato; J C Martínez; A I Saez; B Martinez-Delgado; J F García; M S Mateo; L Sanchez-Verde; J Benítez; P Martínez; M A Piris
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

5.  Pharmacological DNA demethylation restores SMAD1 expression and tumor suppressive signaling in diffuse large B-cell lymphoma.

Authors:  Anna Stelling; Cheuk-Ting Wu; Katrin Bertram; Hind Hashwah; Alexandre P A Theocharides; Markus G Manz; Alexandar Tzankov; Anne Müller
Journal:  Blood Adv       Date:  2019-10-22

Review 6.  Epigenetics and Lymphoma: Can We Use Epigenetics to Prime or Reset Chemoresistant Lymphoma Programs?

Authors:  Jennifer K Lue; Jennifer E Amengual; Owen A O'Connor
Journal:  Curr Oncol Rep       Date:  2015-09       Impact factor: 5.075

7.  p16(INK4a) gene alterations are frequent in lesions of mycosis fungoides.

Authors:  I C Navas; P L Ortiz-Romero; R Villuendas; P Martínez; C García; E Gómez; J L Rodriguez; D García; F Vanaclocha; L Iglesias; M A Piris; P Algara
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

Review 8.  Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas.

Authors:  Richard J Bende; Febe van Maldegem; Carel J M van Noesel
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

9.  Distinct methylated profiles in Helicobacter pylori dependent and independent gastric MALT lymphomas.

Authors:  Y Kaneko; S Sakurai; M Hironaka; S Sato; S Oguni; Y Sakuma; K Sato; K Sugano; K Saito
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

Review 10.  Therapy of gastric mucosa associated lymphoid tissue lymphoma.

Authors:  Andrea Morgner; Renate Schmelz; Christian Thiede; Manfred Stolte; Stephan Miehlke
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.